(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSIÇÃO E USO PARA O TRATAMENTO DE DOENÇA DE PARKINSON E DISTÚRBIOS RELACIONADOS

Em ExigênciaInvention PatentPCT · US2019052705

Application data

Number

112021008087

Type

Invention Patent

Filing

09/24/2019

Publication

08/03/2021

PCT

US2019052705

Progress at the INPI

Technical opinion to answer
  1. Filing09/24/19
  2. Publication08/03/21
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 09/19/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

C. C. (pessoa física)

US

See this company's full portfolio

Inventors

K. C. (pessoa física)

US

T. C. (pessoa física)

US

Technical data

Priority claims

US

62/735,997 · 09/25/2018

US

62/785,602 · 12/27/2018

US

62/785,605 · 12/27/2018

US

62/785,606 · 12/27/2018

US

62/787,614 · 01/02/2019

US

62/817,274 · 03/12/2019

US

62/840,539 · 04/30/2019

Abstract

A presente invenção refere-se a uma combinação farmacêutica que compreende um inibidor de efeitos adversos do agonista de dopamina e um agonista de dopamina, para o tratamento da doença de Parkinson e distúrbios relacionados à doença de Parkinson.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

09/19/2023

RPI 2750

8.7

08/15/2023

RPI 2745

Arquivamento por falta de pagamento

#8.6

Referente à 4ª anuidade.

07/18/2023

RPI 2741

Notificação de entrada na fase nacional - PCT

#1.3

08/03/2021

RPI 2639

Alteração de dados cadastrais

#1.1

05/11/2021

RPI 2627

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.